As the potential of mRNA-based medicines expands, researchers are making exciting strides in overcoming the challenges associated with the intrinsic instability and immunostimulatory properties of exogenous mRNA. By introducing various modifications through chemical or enzymatic methods across the entire mRNA sequence—from cap to tail—translational activity can be enhanced, and immunogenicity risks reduced. To that end, […]